Quantum-Si, Inc. (QSI)
1.75
+0.03
(+1.74%)
USD |
NASDAQ |
Oct 29, 16:00
1.61
-0.14
(-8.00%)
After-Hours: 20:00
Quantum-Si Enterprise Value : 274.56M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 274.56M |
| October 28, 2026 | 267.99M |
| October 27, 2026 | 252.67M |
| October 26, 2026 | 211.08M |
| October 23, 2026 | 197.95M |
| October 22, 2026 | 143.23M |
| October 21, 2026 | 160.74M |
| October 20, 2026 | 145.42M |
| October 19, 2026 | 130.10M |
| October 16, 2026 | 136.66M |
| October 15, 2026 | 178.25M |
| October 14, 2026 | 195.76M |
| October 13, 2026 | 200.14M |
| October 12, 2026 | 189.19M |
| October 09, 2026 | 226.40M |
| October 08, 2026 | 158.55M |
| October 07, 2026 | 171.68M |
| October 06, 2026 | 158.55M |
| October 05, 2026 | 171.68M |
| October 02, 2026 | 230.78M |
| October 01, 2026 | 204.52M |
| September 30, 2026 | 125.72M |
| September 29, 2026 | 101.22M |
| September 28, 2026 | 65.52M |
| September 25, 2026 | 74.13M |
| Date | Value |
|---|---|
| September 24, 2026 | 63.34M |
| September 23, 2026 | 57.58M |
| September 22, 2026 | 63.27M |
| September 21, 2026 | 56.97M |
| September 18, 2026 | 54.60M |
| September 17, 2026 | 60.05M |
| September 16, 2026 | 51.32M |
| September 15, 2026 | 49.11M |
| September 14, 2026 | 50.20M |
| September 11, 2026 | 53.49M |
| September 10, 2026 | 53.29M |
| September 09, 2026 | 55.67M |
| September 08, 2026 | 57.86M |
| September 04, 2026 | 59.18M |
| September 03, 2026 | 58.08M |
| September 02, 2026 | 58.08M |
| September 01, 2026 | 57.27M |
| August 31, 2026 | 59.16M |
| August 28, 2026 | 62.24M |
| August 27, 2026 | 67.30M |
| August 26, 2026 | 64.56M |
| August 25, 2026 | 76.97M |
| August 24, 2026 | 59.90M |
| August 21, 2026 | 74.28M |
| August 20, 2026 | 62.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Champions Oncology, Inc. | 74.13M |
| Medpace Holdings, Inc. | 18.37B |
| Avantor, Inc. | 14.52B |
| Personalis, Inc. | 1.519B |
| Adaptive Biotechnologies Corp. | 4.555B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.53M |
| Revenue (Quarterly) | 0.344M |
| Total Expenses (Quarterly) | 23.88M |
| EPS Diluted (Quarterly) | -0.108 |
| Gross Profit Margin (Quarterly) | -298.8% |
| Profit Margin (Quarterly) | -6.84K% |
| Earnings Yield | -26.46% |
| Normalized Earnings Yield | -24.01 |